MabPlex provides global CDMO services in development and manufacturing of biopharmaceuticals, including mAb, recombinant proteins, ADCs and bispecifics, from upstream cell line development and process development to manufacturing of commercial products. We offer our partners contract services from DNA to finished biopharmaceutical goods. Our technical expertise allows us to provide effective high quality solutions for our partners biomanufacturing needs. At both our US R&D site and our manufacturing site in Yantai, China, MabPlex delivers our commitment to our partners through our quality manufacturing, meeting their expectations.
- Comprehensive biologics development and manufacturing solutions for customers globally
- Multiple Single Use 2000L Bioreactors for GMP Manufacturing
- One of the few providers of large-scale ADC production worldwide
- Services for pre-clinical studies through commercial production
- Senior Management Team averaging over 20 years of industry experience globally
MabPlex is an industry leader in biopharmaceutical contract manufacturing, from development to large-scale GMP manufacturing.
FIRST IN ASIA
MabPlex manufactured the first ADC in clinical trials in China.